265 related articles for article (PubMed ID: 19606088)
21. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.
Colom H; Lloberas N; Andreu F; Caldés A; Torras J; Oppenheimer F; Sanchez-Plumed J; Gentil MA; Kuypers DR; Brunet M; Ekberg H; Grinyó JM
Kidney Int; 2014 Jun; 85(6):1434-43. PubMed ID: 24402086
[TBL] [Abstract][Full Text] [Related]
24. The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
Naesens M; de Loor H; Vanrenterghem Y; Kuypers DR
Transplantation; 2007 Aug; 84(3):362-73. PubMed ID: 17700162
[TBL] [Abstract][Full Text] [Related]
25. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
26. The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients.
Xia ZW; Jun CY; Hao C; Bing C; Min SM; Jie XJ
Eur J Clin Pharmacol; 2010 Jul; 66(7):671-9. PubMed ID: 20473489
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.
Ting LS; Benoit-Biancamano MO; Bernard O; Riggs KW; Guillemette C; Ensom MH
Pharmacotherapy; 2010 Nov; 30(11):1097-108. PubMed ID: 20973683
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
Jain A; Venkataramanan R; Hamad IS; Zuckerman S; Zhang S; Lever J; Warty VS; Fung JJ
J Clin Pharmacol; 2001 Mar; 41(3):268-76. PubMed ID: 11269567
[TBL] [Abstract][Full Text] [Related]
30. Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
Kuypers DR; Vanrenterghem Y; Squifflet JP; Mourad M; Abramowicz D; Oellerich M; Armstrong V; Shipkova M; Daems J
Ther Drug Monit; 2003 Oct; 25(5):609-22. PubMed ID: 14508385
[TBL] [Abstract][Full Text] [Related]
31. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation.
Stracke S; Shipkova M; Mayer J; Keller F; Zarghom A; Yang L; Henne-Bruns D; Wieland E
Clin Transplant; 2012; 26(1):57-66. PubMed ID: 21299636
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.
Tedesco-Silva H; Bastien MC; Choi L; Felipe C; Campestrini J; Picard F; Schmouder R
Transplant Proc; 2005 Mar; 37(2):852-5. PubMed ID: 15848554
[TBL] [Abstract][Full Text] [Related]
36. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
Morissette P; Albert C; Busque S; St-Louis G; Vinet B
Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients.
Kofler S; Deutsch MA; Bigdeli AK; Shvets N; Vogeser M; Mueller TH; Meiser B; Steinbeck G; Reichart B; Kaczmarek I
J Heart Lung Transplant; 2009 Jun; 28(6):605-11. PubMed ID: 19481022
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
Shen B; Chen B; Zhang W; Mao H; Shen C; Deng X; Zhan X; Chen H
Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
[TBL] [Abstract][Full Text] [Related]
39. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.
Hummel M; Yonan N; Ross H; Miller LW; Sechaud R; Balez S; Koelle EU; Gerosa G;
Clin Transplant; 2007; 21(1):18-23. PubMed ID: 17302587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
